Sino Biopharmaceutical Ltd (1177.HK)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|24||2015||Executive Chairlady of the Board|
|65||2016||Chief Executive Officer, Executive Director|
|53||2017||Executive Vice Chairlady of the Board|
|60||2008||Vice Chairman of the Board and the General Manager of Qingdao Haier|
|45||Vice President - Finance of CT Tianqing|
- BRIEF-Sino Biopharmaceutical Gets Approval From China FDA To Register Unit's Drug
- BRIEF-Sino Biopharmaceutical Says Compound Sodium Acetate Ringer's Injection Gets Drug Registration Approvals
- BRIEF-Sino Biopharmaceutical Announces Proposed Bonus Issue Of Shares
- BRIEF-Sino Biopharmaceutical Says FY Profit Attributable Up 32.6 Pct